$DSS
DSS, INC.

2024 Q4 Form 10-Q Financial Statement

#000149315224045198 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2024 Q2
Revenue $5.599M $4.211M
YoY Change 33.88% -41.78%
Cost Of Revenue $5.673M
YoY Change 17.4%
Gross Profit -$1.462M
YoY Change -160.89%
Gross Profit Margin -34.72%
Selling, General & Admin $3.667M $3.473M
YoY Change 14.13% -60.76%
% of Gross Profit
Research & Development $0.00
YoY Change -100.0%
% of Gross Profit
Depreciation & Amortization $554.0K
YoY Change -57.84%
% of Gross Profit
Operating Expenses $10.27M $9.146M
YoY Change 10.61% -33.16%
Operating Profit -$4.671M -$4.935M
YoY Change -8.47% -23.49%
Interest Expense $53.00K $142.0K
YoY Change 3.92% 2.9%
% of Operating Profit
Other Income/Expense, Net $2.000K $12.00K
YoY Change -104.55% -91.84%
Pretax Income -$5.701M -$5.142M
YoY Change -14.67% -86.37%
Income Tax -$188.0K
% Of Pretax Income
Net Earnings -$5.283M -$4.683M
YoY Change 21.67% -87.65%
Net Earnings / Revenue -94.36% -111.21%
Basic Earnings Per Share -$0.75 -$0.66
Diluted Earnings Per Share -$0.75 -$0.66
COMMON SHARES
Basic Shares Outstanding 7.067M shares 7.067M shares 7.067M shares
Diluted Shares Outstanding 7.067M shares 7.067M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.72M
YoY Change 5.28%
Cash & Equivalents $11.60M $10.70M
Short-Term Investments
Other Short-Term Assets $46.97M
YoY Change 1624.9%
Inventory $3.307M $3.572M
Prepaid Expenses
Receivables $2.653M $2.531M
Other Receivables $3.907M
Total Short-Term Assets $68.81M $67.70M
YoY Change 181.96% 127.23%
LONG-TERM ASSETS
Property, Plant & Equipment $5.860M $6.054M
YoY Change -52.55% -51.33%
Goodwill $26.86M $26.86M
YoY Change -53.59% -53.59%
Intangibles
YoY Change
Long-Term Investments $131.0K $135.0K
YoY Change -2.24% -2.88%
Other Assets $133.0K $139.0K
YoY Change -45.93% -46.74%
Total Long-Term Assets $73.85M $76.75M
YoY Change -57.1% -56.16%
TOTAL ASSETS
Total Short-Term Assets $68.81M $67.70M
Total Long-Term Assets $73.85M $76.75M
Total Assets $142.7M $144.4M
YoY Change -27.42% -29.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.399M $3.430M
YoY Change 16.24% 12.61%
Accrued Expenses $2.650M
YoY Change -28.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $49.87M $49.13M
YoY Change 6.94% 4.08%
Total Short-Term Liabilities $59.08M $57.67M
YoY Change 10.49% 3.92%
LONG-TERM LIABILITIES
Long-Term Debt $7.443M $7.029M
YoY Change -3.92% -2.62%
Other Long-Term Liabilities $6.603M
YoY Change 1202.37%
Total Long-Term Liabilities $7.443M $7.029M
YoY Change -9.83% -9.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $59.08M $57.67M
Total Long-Term Liabilities $7.443M $7.029M
Total Liabilities $72.98M $64.70M
YoY Change 18.23% 2.34%
SHAREHOLDERS EQUITY
Retained Earnings -$270.2M -$264.9M
YoY Change 19.63% 19.59%
Common Stock $141.0K $140.0K
YoY Change -94.97% -95.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $52.12M $55.17M
YoY Change
Total Liabilities & Shareholders Equity $142.7M $144.4M
YoY Change -27.42% -29.49%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$5.283M -$4.683M
YoY Change 21.67% -87.65%
Depreciation, Depletion And Amortization $554.0K
YoY Change -57.84%
Cash From Operating Activities -$3.424M
YoY Change -37.93%
INVESTING ACTIVITIES
Capital Expenditures $26.00K
YoY Change -126.53%
Acquisitions
YoY Change
Other Investing Activities $3.705M
YoY Change 112.81%
Cash From Investing Activities $3.679M
YoY Change 100.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.212M
YoY Change -5609.09%
NET CHANGE
Cash From Operating Activities -3.424M
Cash From Investing Activities 3.679M
Cash From Financing Activities 1.212M
Net Change In Cash 1.467M
YoY Change -139.66%
FREE CASH FLOW
Cash From Operating Activities -$3.424M
Capital Expenditures $26.00K
Free Cash Flow -$3.450M
YoY Change -36.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18920000 usd
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
6603000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11631000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6615000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2653000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3994000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
3307000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2819000 usd
CY2024Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
46071000 usd
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
51595000 usd
CY2024Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
3365000 usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
8772000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1779000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
839000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
68806000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
74634000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5860000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6417000 usd
CY2024Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
6199000 usd
CY2023Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
6279000 usd
CY2024Q3 us-gaap Other Investments
OtherInvestments
1282000 usd
CY2023Q4 us-gaap Other Investments
OtherInvestments
1282000 usd
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
131000 usd
CY2024Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
7263000 usd
CY2023Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
9979000 usd
CY2024Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
254000 usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
111000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
133000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
97000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6654000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7210000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
26862000 usd
CY2024Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
19213000 usd
CY2023Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
20193000 usd
CY2024Q3 us-gaap Assets
Assets
142657000 usd
CY2023Q4 us-gaap Assets
Assets
153192000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3399000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3654000 usd
CY2024Q3 DSS Accrued Expenses And Deferred Revenue Current
AccruedExpensesAndDeferredRevenueCurrent
2411000 usd
CY2023Q4 DSS Accrued Expenses And Deferred Revenue Current
AccruedExpensesAndDeferredRevenueCurrent
2511000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2760000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
983000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
638000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
686000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
49873000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
47776000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
59081000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
55610000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7443000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7451000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6454000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6917000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.02
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
47000 shares
CY2024Q3 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5599000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4182000 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
6072000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3667000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3213000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
10270000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
9285000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4671000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5103000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
28000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-44000 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
53000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
51000 usd
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6000 usd
CY2024Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
-449000 usd
CY2023Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
301000 usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0000771999
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 us-gaap Dividend Income Operating
DividendIncomeOperating
usd
CY2023Q3 us-gaap Dividend Income Operating
DividendIncomeOperating
usd
us-gaap Dividend Income Operating
DividendIncomeOperating
usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
usd
CY2024Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
CY2024Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
usd
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations
usd
CY2023 DSS Disposal Group Including Discontinued Operation Impairment Of Assets
DisposalGroupIncludingDiscontinuedOperationImpairmentOfAssets
usd
CY2023 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
usd
us-gaap Stock Issued1
StockIssued1
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-32146
dei Entity Registrant Name
EntityRegistrantName
DSS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
16-1229730
dei Entity Address Address Line1
EntityAddressAddressLine1
275 Wiregrass Pkwy
dei Entity Address City Or Town
EntityAddressCityOrTown
West Henrietta
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
14586
dei City Area Code
CityAreaCode
(585)
dei Local Phone Number
LocalPhoneNumber
325-3610
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, $0.02 par value per share
dei Trading Symbol
TradingSymbol
DSS
dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7066772 shares
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.02
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
128000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
26862000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
72979000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
69978000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.02
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
47000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1000
CY2024Q3 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
0 usd
CY2023Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7066772 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7066772 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7066772 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7066772 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
141000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
140000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
322189000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
319963000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-270210000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-256176000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
52120000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
63927000 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
17559000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
19287000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
69679000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
83214000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
142657000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
153192000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13681000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
17266000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
18179000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10702000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16308000 usd
us-gaap Operating Expenses
OperatingExpenses
27968000 usd
us-gaap Operating Expenses
OperatingExpenses
34487000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-14287000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-15567000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
682000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
331000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1220000 usd
us-gaap Dividend Income Operating
DividendIncomeOperating
12000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
39000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
138000 usd
us-gaap Interest Expense
InterestExpense
242000 usd
us-gaap Interest Expense
InterestExpense
438000 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
8000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-28000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-1021000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-2471000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
6220000 usd
CY2024Q3 DSS Provision For Loan Losses
ProvisionForLoanLosses
-562000 usd
CY2023Q3 DSS Provision For Loan Losses
ProvisionForLoanLosses
-1179000 usd
DSS Provision For Loan Losses
ProvisionForLoanLosses
-908000 usd
DSS Provision For Loan Losses
ProvisionForLoanLosses
-4936000 usd
CY2023Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-1281000 usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
165000 usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-1281000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5701000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6681000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15925000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29571000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-163000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-5701000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-6681000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-15762000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-29580000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-3481000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-5701000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-6681000 usd
us-gaap Profit Loss
ProfitLoss
-15762000 usd
us-gaap Profit Loss
ProfitLoss
-33061000 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-418000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2339000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1728000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2736000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5283000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4342000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14034000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30325000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5283000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4342000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-14034000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-27033000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-3292000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-5283000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4342000 usd
us-gaap Net Income Loss
NetIncomeLoss
-14034000 usd
us-gaap Net Income Loss
NetIncomeLoss
-30325000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.99
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.87
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.99
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.87
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.47
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.47
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7066772 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7013213 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7066772 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6990456 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7066772 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7013213 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7066772 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6990456 shares
us-gaap Profit Loss
ProfitLoss
-15762000 usd
us-gaap Profit Loss
ProfitLoss
-33061000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-3481000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-15762000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-29580000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1692000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4150000 usd
DSS Equity Method Investments Gain Loss
EquityMethodInvestmentsGainLoss
3000 usd
DSS Equity Method Investments Gain Loss
EquityMethodInvestmentsGainLoss
-28000 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-1021000 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-4292000 usd
DSS Change In Right Of Use Assets
ChangeInRightOfUseAssets
-556000 usd
DSS Change In Right Of Use Assets
ChangeInRightOfUseAssets
-749000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
165000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1281000 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
6220000 usd
DSS Provision For Loan Loss
ProvisionForLoanLoss
-1627000 usd
DSS Provision For Loan Loss
ProvisionForLoanLoss
-4936000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1557000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2520000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
488000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4368000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
80000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-323000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
36000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2448000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-255000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2896000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-111000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-15549000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-511000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-763000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1777000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-81000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9181000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-17554000 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-3481000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9181000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21035000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
679000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1861000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5140000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
215000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
3029000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
11330000 usd
DSS Payments To Acquire Notes Receivables
PaymentsToAcquireNotesReceivables
402000 usd
DSS Payments To Acquire Notes Receivables
PaymentsToAcquireNotesReceivables
400000 usd
us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
4039000 usd
us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
1419000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9916000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11885000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1492000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4056000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3546000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
813000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2227000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4281000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3243000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations
5016000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations
-8912000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations
-3481000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6615000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19290000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11631000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6897000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
156681000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
268000 usd
us-gaap Dividends Sharebased Compensation Paid In Kind
DividendsSharebasedCompensationPaidInKind
1206000 usd
us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
5064000 usd
us-gaap Profit Loss
ProfitLoss
-33061000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
127746000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
83214000 usd
DSS Stock Issued During Period Value Initial Public Offering
StockIssuedDuringPeriodValueInitialPublicOffering
2227000 usd
us-gaap Profit Loss
ProfitLoss
-15762000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
69679000 usd
CY2023Q2 DSS Deconsolidation On Loss Before Income Taxes
DeconsolidationOnLossBeforeIncomeTaxes
6220000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zH3oQs1ABoda" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zAjLRvPI7h29">Use of Estimates</span> - </i></b>The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires the Company to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, the Company evaluates its estimates, including those related to the accounts receivable, convertible notes receivable, inventory, fair values of investments, intangible assets and goodwill, useful lives of intangible assets and property and equipment, fair values of options and warrants to purchase the Company’s common stock, preferred stock, deferred revenue and income taxes, among others. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_844_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zArOykRzEpEb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i><span id="xdx_869_zkqV0S70QUF4">Reclassifications</span></i></b><i> </i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- Cost associated with Professional fees for the three and nine months ended September 30, 2023 and the nine months September 30, 2024 have been reclassified to Research and development to conform with current period presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2497000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2494000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zEfSm3oZiybh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zKhvalKZeNLb">Concentration of Credit Risk</span></i></b> - The Company maintains its cash in bank deposit accounts, which at times may exceed federally insured limits. The Company believes it is not exposed to any significant credit risk because of any non-performance by the financial institutions. As of September 30, 2024, two customers accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zBzMPdZUOydg" title="Concentration Risk, Percentage">20</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zSREZu7Bpvb1" title="Concentration Risk, Percentage">10</span>% of our consolidated revenue and two customers accounted for approximately <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zvrav8htEIE2" title="Concentration Risk, Percentage">26</span>% and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zRc03vaNMpj6" title="Concentration Risk, Percentage">23</span>% of our trade accounts receivable balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, one customer accounted for approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zXlpOMjhJGj7" title="Concentration Risk, Percentage">21</span>% of our consolidated revenue and two customers accounted for approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zcH8JvRlT7B1" title="Concentration Risk, Percentage">32</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zYpD5ITi8AC4" title="Concentration Risk, Percentage">15</span>% of our consolidated trade accounts receivable balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, two customers accounted for approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zcK33oWlKM34" title="Concentration Risk, Percentage">20</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zozPeCv5COMd" title="Concentration Risk, Percentage">11</span>% of our consolidated revenue and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zEdZwzzWsxIe" title="Concentration Risk, Percentage">39</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z2AP1ce40uS4" title="Concentration Risk, Percentage">30</span>% of our trade accounts receivable balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Other Assets
OtherAssets
65000 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
7418000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11600000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11600000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
4100000 usd
CY2024Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
46100000 usd
DSS Deconsolidation On Loss Before Income Taxes
DeconsolidationOnLossBeforeIncomeTaxes
29900000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
18700000 usd
CY2024Q3 DSS Increase In Accumulated Deficit
IncreaseInAccumulatedDeficit
23500000 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2210000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2218000 usd
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
489000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
180000 usd
CY2024Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
653000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
439000 usd
CY2024Q3 us-gaap Inventory Gross
InventoryGross
3352000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
2837000 usd
CY2024Q3 us-gaap Inventory Adjustments
InventoryAdjustments
45000 usd
CY2023Q4 us-gaap Inventory Adjustments
InventoryAdjustments
18000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
3307000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2819000 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
37089000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-18195000 usd
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
18894000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
11631000 usd
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
7263000 usd
CY2023 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
33919000 usd
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-17325000 usd
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
16594000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
6615000 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
9979000 usd
CY2024Q2 us-gaap Other Expenses
OtherExpenses
5758000 usd
CY2024Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
5593000 usd
CY2024Q2 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
165000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
49873000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
858000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
902000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
948000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
996000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
3739000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
240000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
861000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
839000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
808000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
824000 usd
CY2024Q3 DSS Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
4913000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8485000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1393000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
7092000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
638000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6454000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y10M24D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.041 pure
DSS Cash Paid For Leases
CashPaidForLeases
786000 usd
DSS Cash Paid For Leases
CashPaidForLeases
931000 usd
CY2024Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 20
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
5333 shares
CY2023Q4 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
reverse stock split of 1 for 55
CY2023Q3 DSS Number Of Shares Owned
NumberOfSharesOwned
4 shares
CY2023 DSS Impairment Of Assets Due To Deconsolidation
ImpairmentOfAssetsDueToDeconsolidation
6220000 usd
CY2023Q4 us-gaap Equity Method Investment Quoted Market Value
EquityMethodInvestmentQuotedMarketValue
74000 usd
CY2023 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
4325000 usd
CY2023 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
2055000 usd
CY2023 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
5743000 usd
CY2023 DSS Disposal Group Including Discontinued Cost Of Operation Expense Net
DisposalGroupIncludingDiscontinuedCostOfOperationExpenseNet
7798000 usd
CY2023 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-3473000 usd
CY2023 DSS Disposal Group Including Discontinued Operation Other Income Expense
DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
-96000 usd
CY2023 us-gaap Disposal Group Including Discontinued Operation Interest Income
DisposalGroupIncludingDiscontinuedOperationInterestIncome
6000 usd
CY2023 DSS Disposal Group Including Discontinued Operation Gain Loss On Investments
DisposalGroupIncludingDiscontinuedOperationGainLossOnInvestments
82000 usd
CY2023 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-3481000 usd
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-3481000 usd
us-gaap Interest Paid Net
InterestPaidNet
631000 usd
us-gaap Interest Paid Net
InterestPaidNet
3432000 usd
us-gaap Stock Issued1
StockIssued1
268000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5 segments

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001493152-24-045198-index-headers.html Edgar Link pending
0001493152-24-045198-index.html Edgar Link pending
0001493152-24-045198.txt Edgar Link pending
0001493152-24-045198-xbrl.zip Edgar Link pending
dss-20240930.xsd Edgar Link pending
ex10-1.htm Edgar Link pending
ex10-1_001.jpg Edgar Link pending
ex10-1_002.jpg Edgar Link pending
ex10-1_003.jpg Edgar Link pending
ex10-1_004.jpg Edgar Link pending
ex10-1_005.jpg Edgar Link pending
ex10-1_006.jpg Edgar Link pending
ex10-1_007.jpg Edgar Link pending
ex10-1_008.jpg Edgar Link pending
ex10-1_009.jpg Edgar Link pending
ex10-2.htm Edgar Link pending
ex10-2_001.jpg Edgar Link pending
ex10-2_002.jpg Edgar Link pending
ex10-2_003.jpg Edgar Link pending
ex10-2_004.jpg Edgar Link pending
ex10-2_005.jpg Edgar Link pending
ex10-2_006.jpg Edgar Link pending
ex10-2_007.jpg Edgar Link pending
ex10-2_008.jpg Edgar Link pending
ex10-2_009.jpg Edgar Link pending
ex10-2_010.jpg Edgar Link pending
ex10-2_011.jpg Edgar Link pending
ex10-2_012.jpg Edgar Link pending
ex10-2_013.jpg Edgar Link pending
ex10-2_014.jpg Edgar Link pending
ex10-2_015.jpg Edgar Link pending
ex10-2_016.jpg Edgar Link pending
dss-20240930_cal.xml Edgar Link unprocessable
dss-20240930_def.xml Edgar Link unprocessable
dss-20240930_lab.xml Edgar Link unprocessable
dss-20240930_pre.xml Edgar Link unprocessable
ex10-2_017.jpg Edgar Link pending
ex10-2_018.jpg Edgar Link pending
ex10-2_019.jpg Edgar Link pending
ex10-2_020.jpg Edgar Link pending
ex10-2_021.jpg Edgar Link pending
ex10-2_022.jpg Edgar Link pending
ex10-2_023.jpg Edgar Link pending
ex10-2_024.jpg Edgar Link pending
ex10-2_025.jpg Edgar Link pending
ex10-2_026.jpg Edgar Link pending
ex10-2_027.jpg Edgar Link pending
ex10-2_028.jpg Edgar Link pending
ex10-2_029.jpg Edgar Link pending
ex10-2_030.jpg Edgar Link pending
ex3-1.htm Edgar Link pending
ex3-1_001.jpg Edgar Link pending
ex3-1_002.jpg Edgar Link pending
ex3-1_003.jpg Edgar Link pending
ex3-1_004.jpg Edgar Link pending
ex3-1_005.jpg Edgar Link pending
ex3-1_006.jpg Edgar Link pending
ex3-1_007.jpg Edgar Link pending
ex3-1_008.jpg Edgar Link pending
ex3-1_009.jpg Edgar Link pending
ex3-1_010.jpg Edgar Link pending
ex3-1_011.jpg Edgar Link pending
ex3-1_012.jpg Edgar Link pending
ex3-1_013.jpg Edgar Link pending
ex3-1_014.jpg Edgar Link pending
ex3-1_015.jpg Edgar Link pending
ex3-1_016.jpg Edgar Link pending
ex3-1_017.jpg Edgar Link pending
ex3-1_018.jpg Edgar Link pending
ex3-1_019.jpg Edgar Link pending
ex3-1_020.jpg Edgar Link pending
ex3-1_021.jpg Edgar Link pending
ex3-1_022.jpg Edgar Link pending
ex3-1_023.jpg Edgar Link pending
ex3-1_024.jpg Edgar Link pending
ex3-1_025.jpg Edgar Link pending
ex3-1_026.jpg Edgar Link pending
ex3-1_027.jpg Edgar Link pending
ex3-1_028.jpg Edgar Link pending
ex3-1_029.jpg Edgar Link pending
ex3-1_030.jpg Edgar Link pending
ex3-1_031.jpg Edgar Link pending
ex3-1_032.jpg Edgar Link pending
ex3-1_033.jpg Edgar Link pending
ex3-1_034.jpg Edgar Link pending
ex3-1_035.jpg Edgar Link pending
ex3-1_036.jpg Edgar Link pending
ex3-1_037.jpg Edgar Link pending
ex3-1_038.jpg Edgar Link pending
ex3-1_039.jpg Edgar Link pending
ex3-1_040.jpg Edgar Link pending
ex3-1_041.jpg Edgar Link pending
ex3-1_042.jpg Edgar Link pending
ex3-1_043.jpg Edgar Link pending
ex3-1_044.jpg Edgar Link pending
ex3-1_045.jpg Edgar Link pending
ex3-1_046.jpg Edgar Link pending
ex3-1_047.jpg Edgar Link pending
ex3-1_048.jpg Edgar Link pending
ex3-1_049.jpg Edgar Link pending
ex3-1_050.jpg Edgar Link pending
ex3-1_051.jpg Edgar Link pending
ex3-1_052.jpg Edgar Link pending
ex3-1_053.jpg Edgar Link pending
ex3-1_054.jpg Edgar Link pending
ex3-1_055.jpg Edgar Link pending
ex3-1_056.jpg Edgar Link pending
ex3-1_057.jpg Edgar Link pending
ex3-1_058.jpg Edgar Link pending
ex3-1_059.jpg Edgar Link pending
ex3-1_060.jpg Edgar Link pending
ex3-1_061.jpg Edgar Link pending
ex3-1_062.jpg Edgar Link pending
ex3-1_063.jpg Edgar Link pending
ex3-2.htm Edgar Link pending
ex3-3.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending